Article has an altmetric score of 6  

A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes
Journal Article uri icon

Overview

abstract

  • OBJECTIVE: To evaluate whether LY2605541 results in lower fasting blood glucose (FBG) versus insulin glargine (GL). RESEARCH DESIGN AND METHODS: This 12-week, randomized, open-label, Phase 2 study enrolled patients with type 2 diabetes (hemoglobin A(1c) [A1C]

    • Link to Article

    authors

    publication date

  • 2012

    • published in

  • Diabetes care  Journal

    • Research

    keywords

  • Diabetes
  • Drugs and Drug Therapy
  • Randomized Controlled Trials

    • Additional Document Info

    volume

  • 35

    • issue

  • 11